TL02-59

CAT: 0804-HY-112852-01Size: 1 mgDry Ice: NoHazardous: No
CAT#:0804-HY-112852-01Size:1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
TL02-59 is an orally active, selective Src-family kinase Fgr inhibitor with an IC50 of 0.03 nM. TL02-59 inhibits Lyn and Hck with IC50s of 0.1 nM and 160 nM, respectively. TL02-59 potently suppresses acute myelogenous leukemia (AML) cell growth[1].
CAS Number
[1315330-17-6]
UNSPSC
12352005
Target
Apoptosis; Src
Type
Reference compound
Related Pathways
Apoptosis; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tl02-59.html
Purity
99.84
Solubility
DMSO : 100 mg/mL (ultrasonic; warming; heat to 80°C)
Smiles
O=C(NC1=CC=C(CN2CCN(CC)CC2)C(C(F)(F)F)=C1)C3=CC=C(C)C(OC4=C5C=C(OC)C(OC)=CC5=NC=N4)=C3
Molecular Formula
C32H34F3N5O4
Molecular Weight
609.64
References & Citations
[1]Weir MC, et al. Selective Inhibition of the Myeloid Src-Family Kinase Fgr Potently Suppresses AML Cell Growth in Vitro and in Vivo. ACS Chem Biol. 2018 Jun 15;13 (6) :1551-1559.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-174149HDAC6-IN-59
HY-157978AChE-IN-59
HY-136284-01XP-59
HY-157482EBP-59
HY-178960Tubulin-IN-59
HY-172674HPK1-IN-59
HY-147802EGFR-IN-59
HY-163256HSD17B13-IN-59
HY-149369HDAC-IN-59
HY-172892PI3K-IN-59

Alternative Products

CatalogName
M26488-01TL02-59
A20302-200TL02-59 200mg
MF-0031245-01TL02-59 dihydrochloride
A20302-10TL02-59 10mg
A20302-25TL02-59 25mg
A20302-1TL02-59 1mg
A20302-5TL02-59 5mg
A20302-50TL02-59 50mg
A20302-100TL02-59 100mg
A20302-10mM-DTL02-59 10mM * 1mL in DMSO

Popular Products